🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comprehensive Palliative Care After Stem Cell Transplantation: a Feasability Study

RecruitingNAAges 18 Years - anyAllLisa Hentsch
NCT07895693 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

People who receive an allogeneic stem cell transplant often face important physical and emotional challenges during their recovery. Even after leaving the hospital, they may experience symptoms such as fatigue, pain, anxiety, uncertainty, or difficulties returning to their usual daily activities. Family caregivers may also experience a considerable burden during this period. Palliative care is specialized supportive care aimed at improving quality of life for people facing serious illness. It focuses on helping patients and families manage symptoms, cope with emotional and practical challenges, and receive care that is aligned with their needs and priorities. While palliative care is increasingly integrated into cancer care, it is not routinely offered to all patients recovering from stem cell transplantation. The COMPAS study aims to determine whether it is feasible and acceptable to

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years or older. * Undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). * Meet at least one of the following vulnerability criteria: Heavy symptom burden, defined as a score of 3 or higher for at least one symptom on the Edmonton Symptom Assessment System (ESAS); Age 65 years or older; Poor prognosis, defined as a Disease Risk Index (DRI) category of intermediate, high, or very high. * Able to provide written informed consent. * Able to communicate in French and complete study assessments. Exclusion Criteria: * Severe cognitive impairment preventing completion of study questionnaires. * Inability to provide informed consent. * Inability to communicate in French.
💊

What it tests

  • Early Integrated Palliative Care
📍

Where

1 site
Geneva University Hospitals
Geneva, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy